Hydration Dynamics and Influence of Beverage Composition
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Contact
Study Contact
- Name: Craig A Horswill, PhD
- Phone Number: 312-996-5656
- Email: horswill@uic.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- University of Illinois Chicago
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Have a BMI of 18.5 to 29.9 kg/m2.
- Be normotensive (<120/80 mm Hg).
- Must be able to speak and read English.
- Be physically active or a regular exerciser but be able to abstain from exercise for 48 h prior to each study trial.
- Fast for at least 8 hours prior to and through the study trial.
- Be able to abstain from alcohol for 48 h prior to each study.
- Be able to abstain from caffeine for 24 h prior to each study.
- If female, must have regular menstrual cycles, that are > 27 days and < 35 days in length.
Exclusion Criteria:
- Under 18 y of age or over 45 y of age.
- Have a BMI <18.5 or >30.
- Being pregnant.
- Lactating.
- Tobacco user.
- Have hypotension or hypertension.
- Have any type of kidney disease or dysfunction.
- Have diabetes.
- Have any type of cardiovascular disease.
- Have been diagnosed with galactosemia.
- Females with irregular menstrual cycles.
- Females with polycystic ovary disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
Water
|
Ingestion of one (1) liter of beverage with observation for 2 h
|
|
Experimental: Oral rehydration solution 1
Beverage with 2.5% glucose with 45 mmol sodium/L.
|
Ingestion of one (1) liter of beverage with observation for 2 h
|
|
Experimental: Oral rehydration solution 2
Beverage with 1.7% glucose with 60 mmol sodium/L.
|
Ingestion of one (1) liter of beverage with observation for 2 h
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of appearance of deuterium in the plasma for placebo
Time Frame: 2 hours
|
Measure the rate of fluid uptake by the gut using appearance of deuterium oxide, or D2O, in the blood after ingesting a fixed volume of placebo.
|
2 hours
|
|
Rate of appearance of deuterium in the plasma for oral rehydration solution 1.
Time Frame: 2 hours
|
Measure the rate of fluid uptake by the gut using appearance of deuterium oxide, or D2O, in the blood after ingesting a fixed volume of placebo.
|
2 hours
|
|
Rate of appearance of deuterium in the plasma for oral rehydration solution 2.
Time Frame: 2 hours
|
Measure the rate of fluid uptake by the gut using appearance of deuterium oxide, or D2O, in the blood after ingesting a fixed volume of placebo.
|
2 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fluid retention for placebo
Time Frame: 2 hours
|
Measure fluid retention using the difference between ingested volume and cumulative urine excretion as a percentage of the ingested volume.
|
2 hours
|
|
Fluid retention for oral rehydration solution 1
Time Frame: 2 hours
|
Measure fluid retention using the difference between ingested volume and cumulative urine excretion as a percentage of the ingested volume.
|
2 hours
|
|
Fluid retention for oral rehydration solution 2
Time Frame: 2 hours
|
Measure fluid retention using the difference between ingested volume and cumulative urine excretion as a percentage of the ingested volume.
|
2 hours
|
|
Change in plasma volume for placebo
Time Frame: 2 hours
|
Increase in plasma volume (water content of the blood) following ingestion of beverage
|
2 hours
|
|
Change in plasma volume for oral rehydration solution 1
Time Frame: 2 hours
|
Increase in plasma volume (water content of the blood) following ingestion of beverage
|
2 hours
|
|
Change in plasma volume for oral rehydration solution 2
Time Frame: 2 hours
|
Increase in plasma volume (water content of the blood) following ingestion of beverage
|
2 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Craig A Horswill, PhD, University of Illinois at Chicago
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2021-0823
- Abbott Nutrition (EAS) (Other Grant/Funding Number: Non-Federal Industry)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.